SH2D1B and B-cell chronic lymphocytic leukemia: Activation of cell surface SLAMF5/CD84 initiated a signaling cascade (involving EAT-2, Lck, Akt, Bcl-2, and Mcl-1) that enhanced CLL cell survival.